A novel cellular rejuvenation therapy, ER-100, has received clearance from the U.S. Food and Drug Administration (FDA) to proceed with human clinical testing, marking what the sponsor describes as …
Patients undergoing maintenance hemodialysis continue to experience disproportionately high mortality and substantial treatment-related burden. Among the modifiable aspects of dialysis care, treatment duration represents a potentially powerful yet underused lever …
Brief Report: Prevalence and Economic Burden of Chronic Conditions in the Commercially Insured US Population (2024) Overview A 2024 analysis conducted by FAIR Health presents new data regarding the epidemiology …
Key takeaways: Using NHANES data from 2017 to 2023, obesity prevalence in the U.S. is 75.2% when excess adiposity cutoffs are used. Among adults with a BMI of less …
✏️ ADMIN EDIT MODE local_hospital MedJournal dark_mode Research chevron_right Immunology Targeted Immunotherapy in Chronic Autoimmune Disorders A comprehensive analysis of novel monoclonal antibody treatments and their long-term efficacy in Phase …
y
Login/Sign Up – MedResearch Pro MedResearch Pro Research Pricing About Log In Sign Up menu Welcome to MedResearch Pro Join thousands of medical professionals advancing their knowledge. Continue with Google …
Login/Sign Up – MedResearch Pro MedResearch Pro Research Pricing About Log In Sign Up menu Welcome to MedResearch Pro Join thousands of medical professionals advancing their knowledge. Continue with Google …